Latest Insider Transactions at Guardant Health, Inc. (GH)
This section provides a real-time view of insider transactions for Guardant Health, Inc. (GH). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Guardant Health, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Guardant Health, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 21
2025
|
Roberto Mignone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
264
+6.67%
|
-
|
|
Dec 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-1.43%
|
$11,716
$101.46 P/Share
|
|
Dec 17
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
232
+18.4%
|
-
|
|
Dec 15
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
594
-2.17%
|
$60,588
$102.67 P/Share
|
|
Dec 15
2025
|
Chris Freeman Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,402
+4.87%
|
-
|
|
Dec 15
2025
|
Kumud Kalia Chief Information Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
323
-1.4%
|
$32,946
$102.67 P/Share
|
|
Dec 15
2025
|
Kumud Kalia Chief Information Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
637
+2.69%
|
-
|
|
Dec 15
2025
|
John G. Saia Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
535
-1.21%
|
$54,570
$102.67 P/Share
|
|
Dec 15
2025
|
John G. Saia Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,020
+2.26%
|
-
|
|
Dec 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+2.99%
|
-
|
|
Dec 15
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,659
-5.3%
|
$169,218
$102.67 P/Share
|
|
Dec 15
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,272
+5.08%
|
-
|
|
Dec 15
2025
|
Darya Chudova Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
5,451
-43.74%
|
$566,904
$104.04 P/Share
|
|
Dec 15
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
711
-1.56%
|
$72,522
$102.67 P/Share
|
|
Dec 15
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,402
+2.98%
|
-
|
|
Dec 15
2025
|
Helmy Eltoukhy Co-Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
90,565
-2.12%
|
$9,328,195
$103.91 P/Share
|
|
Dec 08
2025
|
Darya Chudova Chief Technology Officer |
SELL
Open market or private sale
|
Indirect |
13,664
-20.05%
|
$1,434,720
$105.04 P/Share
|
|
Dec 08
2025
|
Darya Chudova Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
9,271
-42.66%
|
$982,726
$106.0 P/Share
|
|
Dec 08
2025
|
Darya Chudova Chief Technology Officer |
BUY
Other acquisition or disposition
|
Indirect |
68,144
+50.0%
|
-
|
|
Dec 08
2025
|
Darya Chudova Chief Technology Officer |
SELL
Other acquisition or disposition
|
Direct |
68,144
-75.82%
|
-
|
|
Dec 08
2025
|
Medina Manuel Hidalgo Director |
SELL
Open market or private sale
|
Direct |
1,250
-36.36%
|
$131,250
$105.0 P/Share
|
|
Dec 08
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+32.82%
|
$32,000
$32.55 P/Share
|
|
Dec 08
2025
|
Kumud Kalia Chief Information Officer |
SELL
Open market or private sale
|
Direct |
2,000
-8.21%
|
$208,000
$104.6 P/Share
|
|
Dec 08
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
100,000
-8.16%
|
$10,500,000
$105.18 P/Share
|
|
Dec 08
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
387,946
+47.06%
|
-
|
|
Dec 08
2025
|
Amir Ali Talasaz Co-Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
387,946
-82.4%
|
-
|
|
Dec 05
2025
|
Ian T Clark Director |
SELL
Open market or private sale
|
Indirect |
28,611
-34.38%
|
$3,061,377
$107.33 P/Share
|
|
Dec 05
2025
|
Ian T Clark Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
28,611
+26.1%
|
$1,029,996
$36.09 P/Share
|
|
Dec 05
2025
|
Michael Brian Bell Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
80,362
-10.44%
|
$8,277,286
$104.0 P/Share
|
|
Dec 05
2025
|
Michael Brian Bell Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
56,287
+23.19%
|
$1,688,610
$30.62 P/Share
|
|
Dec 05
2025
|
Chris Freeman Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
31,452
-6.63%
|
$3,239,556
$103.76 P/Share
|
|
Dec 01
2025
|
Terilyn J. Monroe Chief People Officer |
SELL
Open market or private sale
|
Direct |
55,167
-15.71%
|
$5,847,702
$106.4 P/Share
|
|
Dec 01
2025
|
Terilyn J. Monroe Chief People Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+26.45%
|
$1,200,000
$24.38 P/Share
|
|
Nov 30
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
155
+0.83%
|
-
|
|
Nov 21
2025
|
Roberto Mignone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
264
+7.14%
|
-
|
|
Nov 19
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-1.45%
|
$11,136
$96.25 P/Share
|
|
Nov 17
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
232
+18.14%
|
-
|
|
Nov 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+3.04%
|
-
|
|
Nov 07
2025
|
John G. Saia Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
8,996
-17.24%
|
$863,616
$96.25 P/Share
|
|
Nov 07
2025
|
Medina Manuel Hidalgo Director |
SELL
Open market or private sale
|
Direct |
1,500
-40.61%
|
$142,500
$95.2 P/Share
|
|
Nov 07
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+30.17%
|
$32,000
$32.55 P/Share
|
|
Oct 31
2025
|
Steve E. Krognes Director |
BUY
Exercise of conversion of derivative security
|
Direct |
154
+0.83%
|
-
|
|
Oct 21
2025
|
Roberto Mignone Director |
BUY
Exercise of conversion of derivative security
|
Direct |
3,167
+50.0%
|
-
|
|
Oct 17
2025
|
Medina Manuel Hidalgo Director |
BUY
Exercise of conversion of derivative security
|
Direct |
232
+15.0%
|
-
|
|
Oct 17
2025
|
Myrtle S Potter Director |
SELL
Open market or private sale
|
Direct |
26
-0.14%
|
$1,716
$66.95 P/Share
|
|
Oct 17
2025
|
Musa Tariq Director |
SELL
Open market or private sale
|
Direct |
116
-1.48%
|
$7,656
$66.95 P/Share
|
|
Oct 15
2025
|
Myrtle S Potter Director |
BUY
Exercise of conversion of derivative security
|
Direct |
69
+0.37%
|
-
|
|
Oct 15
2025
|
Musa Tariq Director |
BUY
Exercise of conversion of derivative security
|
Direct |
250
+3.09%
|
-
|
|
Oct 01
2025
|
Craig Eagle Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,025
-13.68%
|
$435,550
$62.65 P/Share
|
|
Oct 01
2025
|
Craig Eagle Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
13,859
+8.35%
|
-
|